Bill Title: As introduced, prohibits an insurance policy that provides benefits for anti-cancer medications that are injected or intravenously administered by a healthcare provider and anti-cancer medications that are patient administered from requiring a higher copayment, deductible, or coinsurance amount for the patient administered anti-cancer medication than for the injected or intravenously administered anti-cancer medication. - Amends TCA Title 56, Chapter 7, Part 23.

Spectrum: Partisan Bill (Republican 9-0)

Status: (Introduced - Dead) 2017-04-04 - Action deferred to first calendar of 2018 [SB0922 Detail]

Text: Latest bill text (Draft #1) [PDF]

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2017 Tennessee SB0922 at this time.

Social Comments on TN SB0922